Jefferies Financial Group Inc. Purchases New Stake in Maximus, Inc. $MMS

Jefferies Financial Group Inc. purchased a new stake in Maximus, Inc. (NYSE:MMS – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 10,455 shares of the health services provider’s stock, valued at approximately $556,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of MMS. Root Financial Partners LLC purchased a new stake in Maximus during the third quarter worth approximately $26,000. Integrated Wealth Concepts LLC acquired a new stake in shares of Maximus in the second quarter worth $34,000. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Maximus in the third quarter worth $36,000. Global Retirement Partners LLC purchased a new position in shares of Maximus in the 2nd quarter valued at $40,000. Finally, Archer Investment Corp purchased a new position in shares of Maximus in the 2nd quarter valued at $43,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Maximus

In other news, insider Michelle Link sold 3,208 shares of the business’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $54.23, for a total transaction of $173,969.84. Following the transaction, the insider directly owned 13,881 shares of the company’s stock, valued at approximately $752,766.63. The trade was a 18.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on MMS. Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Maximus in a research report on Monday, August 17th. Finally, Zacks Research upgraded Maximus from a “strong sell” rating to a “hold” rating in a report on Thursday, October 1st. Two equities research analysts have rated the stock with a Hold rating. According to data from MarketBeat, Maximus presently has an average rating of “Hold”.

View Our Latest Stock Analysis on MMS

Maximus Stock Performance

Shares of NYSE:MMS opened at $64.86 on Monday. The company has a market cap of $3.40 billion, a P/E ratio of 9.58 and a beta of 0.56. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. Maximus, Inc. has a one year low of $51.04 and a one year high of $100.00. The business’s 50-day simple moving average is $59.47 and its 200 day simple moving average is $63.56.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Friday, November 13th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend is Friday, November 13th. Maximus’s payout ratio is presently 19.50%.

About Maximus

(Free Report)

Maximus, Inc. provides technology-enabled services to government agencies, helping them administer public programs and deliver services to residents. Its work includes managing contact centers, processing applications and eligibility determinations, conducting health assessments, and supporting appeals and other case-management functions. The company serves clients in the United States and internationally, including government agencies in the United Kingdom, Canada and Australia. Its services span health and human services programs as well as federal government operations, with technology and digital services supporting its program work.

See Also

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.